Clinical Trial Update: Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors [NA]

View source ↗

Summary

Clinical trial update for a dual tracer PET imaging study using 68Ga-DOTATATE and 18F-FDG in grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors; t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroenteropancreatic Neuroendocrine Tumors

Drugs mentioned

• 18F-FDG (fluorodeoxyglucose F-18)
• 68Ga-DOTATATE (Gallium-68 DOTATATE)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Neuroendocrine Tumors | NA | Status: ACTIVE_NOT_RECRUITING